06.09.2021

09:30 - 10:45184CCC Respiratory critical careChallenging clinical cases
09:30 - 11:00185Asthma treatment: clinical and translational scienceOral Presentation
09:30 - 11:00186Adult cystic fibrosisOral Presentation
09:30 - 11:00187Nursing perspective during the COVID-19 pandemicOral Presentation
09:30 - 11:00188Novel insights into the diagnosis, mechanism and treatment of malignant pleural diseaseOral Presentation
09:30 - 11:00189New technologies for the management of children with respiratory diseasesSymposium
09:30 - 11:00190Interstitial lung diseasesState of the art session
09:30 - 11:00191Highlights on gender and respiratory healthSymposium
09:30 - 10:45193Part I: restarting COPD care in the post-COVID eraPrimary care session
09:30 - 11:00194ImagingOral Presentation
10:00 - 12:00195Respiratory sleepSkills lab
10:55 - 12:10198Part II: restarting asthma care in the post-COVID eraPrimary care session
11:15 - 12:45203Updates on inhalers for COPD and asthmaJoint session
11:15 - 12:45204Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseasesOral Presentation
11:15 - 12:45205Advances in treatment and management of tuberculosis and nontuberculous mycobacterial diseaseOral Presentation
11:15 - 12:45206Paediatric lung disease: novel mechanisms, methods and translational studiesOral Presentation
11:15 - 12:45207New trends in non-invasive respiratory supportOral Presentation
11:15 - 12:45208Wheezing illnesses along the life spanSymposium
11:15 - 12:45209LoF Interstitial lung diseases?Lungs on fire
11:15 - 12:45210Sarcopenia in chronic respiratory disease: new definitions, assessment and treatment optionsSymposium
11:15 - 12:45211Digital transformation in practice: enabling next-generation medicineSymposium
11:15 - 12:45212Respiratory infectionsOral Presentation
12:20 - 13:00214The current classification of pulmonary hypertension meets clinical practicePro-Con debate
12:50 - 15:00219Thoracic ultrasoundSkills lab
13:15 - 14:15227Epidemiology and burden of tuberculosis and other lung diseasesE-poster
13:15 - 14:15228PneumoniaE-poster
13:15 - 14:15229Acute non-invasive respiratory therapies in COVID-19 and beyondE-poster
13:15 - 14:15230Environment and air pollutionE-poster
13:15 - 14:15231Innovations in nurse-led interventions in respiratory diseasesE-poster
13:15 - 14:15232Physical activity, exercise training and (tele)rehabilitation in respiratory patientsE-poster
13:15 - 14:15233Treatments for airway diseasesE-poster
13:15 - 14:15234Lung function testing in the management of obstructive diseasesE-poster
13:15 - 14:15235Pulmonary neoplasia and related pathologiesE-poster
13:15 - 14:15236Fungi, viruses, parasites and the immunocompromisedE-poster
13:15 - 14:15237Occupational rhinitis and asthmaE-poster
13:15 - 14:15238Therapy of pulmonary hypertensionE-poster
13:15 - 14:15239Management of chronic cough and obstructive diseasesE-poster
13:15 - 14:15240Acute paediatric respiratory infectionsE-poster
13:15 - 14:15241Rare thoracic surgical disease and the chest wallE-poster
13:15 - 14:15242Pulmonary rehabilitation in clinical conditionsE-poster
13:15 - 14:15243Bronchiectasis and pleural infectionE-poster
13:15 - 14:15244Paediatric asthma and bronchopulmonary dysplasiaE-poster
13:15 - 14:15245In vitro modelling of lung disease: reach out to the next dimensionE-poster
13:15 - 14:15246BronchiectasisE-poster
13:15 - 14:15247Sleep across the lifespan in the new era of COVID - 19E-poster
13:15 - 14:15248Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosisE-poster
13:15 - 14:15249New approaches to pulmonary rehabilitation and chronic careE-poster
13:15 - 14:15250Pharmacology of airway diseases: clinical and laboratory studiesE-poster
13:15 - 14:15251Lung disease burden and managementE-poster
13:15 - 14:15252Early-life infections, wheezing and asthmaE-poster
13:15 - 14:15253Screening, diagnosis, management and prognosis of lung cancerE-poster
13:15 - 14:15254Cystic fibrosisE-poster
13:15 - 14:15255An update on respiratory physiotherapy and respiratory muscle function and trainingE-poster
13:15 - 14:15256Comorbidities in airway obstructive diseasesE-poster
13:15 - 14:15257Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseasesE-poster
13:15 - 14:15258Insights into rehabilitation and physiotherapy in COVID-19E-poster
13:15 - 14:15259Epidemiological aspects of tuberculosisE-poster
13:15 - 14:15260Therapy of lung cancerE-poster
13:15 - 14:15261Environmental and lifestyle impacts on chronic lung diseaseE-poster
13:15 - 14:15262Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseasesE-poster
13:15 - 14:15263Back to infection basicsE-poster
13:15 - 14:15264Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseasesE-poster
13:15 - 14:15265Pathogenic progress in airway diseasesE-poster
13:15 - 14:15266Inhaled treatments for COPD: real-world dataE-poster
13:15 - 14:15267Mechanical ventilation and weaningE-poster
13:15 - 14:15268Health effects of tobacco and medical professionalsE-poster
13:15 - 14:15269Convex probe endobronchial ultrasound and radial probe endobronchial ultrasoundE-poster
13:15 - 14:15270Immunological and molecular characterisation of tuberculosis disease and infectionE-poster
13:15 - 14:15271From phenotyping to different diagnostic tools for sleep breathing disordersE-poster
13:15 - 14:15272Future advances in respiratory physiologyE-poster
13:15 - 14:15273Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trialsE-poster
13:15 - 14:15274Interstitial lung disease, COVID-19 and friendsE-poster
14:35 - 15:50275CCC Interstitial lung diseasesChallenging clinical cases
14:45 - 16:15276New insights into the pathophysiology and prognosis of COPDOral Presentation
14:45 - 16:15277Advances in childhood asthma: biologics, biomarkers and infectionsOral Presentation
14:45 - 16:15278Tobacco and nicotine research during the pandemicOral Presentation
14:45 - 16:15279Insights into pulmonary embolismOral Presentation
14:45 - 16:15280Digital innovations in tuberculosis and implementation research in the era of COVID-19: collaborative activities between the WHO and ERSHot topics
14:45 - 16:15281Precision medicine in asthma and COPDSymposium
14:45 - 16:15282The best of the European Respiratory Journal 2021Journal session
14:45 - 16:15283Respiratory critical careState of the art session
14:45 - 16:15284LoF Lung cancer?Lungs on fire
14:45 - 16:15285Innovation in thoracic surgeryOral Presentation
16:00 - 18:00287Russian programme 2021Language session
16:30 - 18:00293Highlights in COVID-19 diagnosis and treatmentOral Presentation
16:30 - 18:00294Monitoring of lung disease and CFTR function in children with cystic fibrosisOral Presentation
16:30 - 18:00295Impact of COVID - 19, quality assurance and technology on pulmonary functionOral Presentation
16:30 - 18:00296Cellular and molecular involvement in lung injury and repairOral Presentation
16:30 - 18:00298New insights into nontuberculous mycobacteria disease: from diagnosis to treatmentSymposium
16:30 - 18:00299Pharmacology of lung immune responses: which pathways to target!Symposium
16:30 - 18:00300The "State of the Art" in the diagnosis of bacterial, mycobacterial, and fungal pneumoniasJournal session
16:30 - 18:00301LoF Respiratory critical care / Sleep and Breathing disordersLungs on fire
16:30 - 18:00302Lung cancer grand roundGrand round
16:30 - 18:00303Innovation in respiratory trainingOral Presentation